Insider sale
DYNE THERAPEUTICS, INC.
$7.02M
268.35K shares
What this filing means
ATLAS VENTURE FUND XI, L.P. plans to sell 268.35K shares of DYNE THERAPEUTICS, INC. valued at approximately $7.02M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/13/2026ACC: 0001628280-26-056843
10% Owner
Since Sep 2020
268.35K
Shares to sell
$7.02M
Approx. market value
268.35K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Private Placement
Cash
7/31/2020
268.35KTotal acquired268.35K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/31/2020 | Private Placement Cash | 268.35K | — |
| Total | 268.35K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
268.35K
Market value
$7.02M
8/13/2026
Total
Units
268.35K
Value
$7.02M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/13/2026 | 268.35K | $7.02M | Nasdaq | Planned |
| Total | 268.35K | $7.02M | ||